Home/Filings/4/0001142576-09-000032
4//SEC Filing

Shue Youe Kong 4

Accession 0001142576-09-000032

CIK 0001142576other

Filed

Dec 1, 7:00 PM ET

Accepted

Dec 2, 5:08 PM ET

Size

9.5 KB

Accession

0001142576-09-000032

Insider Transaction Report

Form 4
Period: 2009-12-01
Shue Youe Kong
VP, clinical Development
Transactions
  • Purchase

    Common Stock

    2009-12-02$10.89/sh+500$5,44582,648 total
  • Purchase

    Common Stock

    2009-12-01$11.10/sh+1,000$11,10080,648 total
  • Purchase

    Common Stock

    2009-12-02$10.90/sh+500$5,45082,148 total
  • Purchase

    Common Stock

    2009-12-02$10.96/sh+1,000$10,96081,648 total
Footnotes (1)
  • [F1]Owned jointly with spouse.

Issuer

OPTIMER PHARMACEUTICALS INC

CIK 0001142576

Entity typeother

Related Parties

1
  • filerCIK 0001380841

Filing Metadata

Form type
4
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 5:08 PM ET
Size
9.5 KB